Who Paid My Doc
Nuwiq
Biological Coagulation
NDC 68982-139-01
General payments
$413,144
Research payments
$164,893
Through program year 2025, $413,144 in general payments and $164,893 in research payments were reported against Nuwiq (Coagulation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
12 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $24,191 | 46 |
| 2024 | General | $114,777 | 164 |
| 2024 | Research | $65,534 | 7 |
| 2023 | General | $99,019 | 195 |
| 2023 | Research | $15,346 | 9 |
| 2022 | General | $33,779 | 77 |
| 2021 | General | $69,011 | 127 |
| 2021 | Research | $2,015 | 2 |
| 2020 | General | $7,548 | 45 |
| 2020 | Research | $8,255 | 4 |
| 2019 | General | $64,820 | 262 |
| 2019 | Research | $73,743 | 33 |
Breakdown
The top 5 of 24 recipients; each share is of general payments naming this product in 2025.
The top 5 of 6 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 17 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
916 general · 55 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.